A novel method for determining antibody-dependent cellular phagocytosis.

Area of Science:

• Immunology
• Pharmacology
• Biotechnology

Background:

• Antibody therapeutics utilize Fab and Fc regions for target binding and effector functions.
• Fc-mediated effector functions like ADCC, CDC, and ADCP are crucial for tumor cell depletion.
• Current in vitro assays for ADCP often fail to distinguish cell attachment from true internalization.

Purpose of the Study:

• To develop and validate a novel, accurate method for quantifying antibody-dependent cellular phagocytosis (ADCP).
• To overcome limitations of existing assays that cannot reliably measure target cell internalization.

Main Methods:

• Development of a novel assay using a pH-sensitive dye to label target cells.
• The dye fluoresces only within mature phagosomes, indicating successful internalization.
• Quantification of ADCP activity using flow cytometry.

Main Results:

• The novel method accurately measures ADCP by detecting phagosome acidification.
• This technique distinguishes true phagocytosis from non-specific cell association.
• Enables reliable in vitro assessment of ADCP for antibody therapeutics.

Conclusions:

• The developed assay provides an accurate and reliable method for quantifying ADCP.
• This advancement is critical for evaluating the efficacy of antibody-based therapeutics.
• Improved ADCP measurement will aid in the development of more effective cancer treatments.